Drug Profile
Doxycycline hyclate - QLT USA
Alternative Names: AtridoxLatest Information Update: 22 Oct 2021
Price :
$50
*
At a glance
- Originator QLT USA
- Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Periodontal disorders
Most Recent Events
- 05 Aug 2016 Meda has been acquired by Mylan
- 01 Oct 2009 QLT USA has been acquired by Tolmar
- 11 Apr 2008 CollaGenex Pharmaceuticals has been acquired by Galderma